Giuseppe Celasco
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Giuseppe Celasco
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy.
12
| Extinct | Pharmaceuticals: Major | 12 |
University of Genoa
6
| College/University | Other Consumer Services | 6 |
Parke Davis SpA
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Giuseppe Celasco
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer Director of Finance/CFO Corporate Officer/Principal Chief Operating Officer General Counsel Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Chairman | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
| University of Milan | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| University of Pavia | College/University | Undergraduate Degree Graduate Degree | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CONAFI S.P.A. | Finance/Rental/Leasing | Director/Board Member | |
Banca Arner (Italia) SpA
 Banca Arner (Italia) SpA Major BanksFinance Part of One Swiss Bank SA, Banca Arner (Italia) SpA is a nationally chartered commercial bank. The private company is based in Milan, Italy. | Major Banks | Chairman | |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Investment Managers | Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree | |
| Controlled Release Society Italy Local Chapter | Director/Board Member | ||
| Italian Pharmaceutical Association | Director/Board Member | ||
Lifematrix Technologies AG
 Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Miscellaneous Commercial Services | Director/Board Member | |
UBS South Africa (Pty) Ltd.
 UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Investment Managers | Corporate Officer/Principal | |
| NEXT RE SIIQ S.P.A. | Real Estate Development | Director/Board Member | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Chairman | |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Forest Products | Director/Board Member | |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Cosmo Bioscience, Inc. | Director/Board Member | ||
Wergen & Partner Vermögensverwaltungs AG
 Wergen & Partner Vermögensverwaltungs AG Financial ConglomeratesFinance Wergen & Partner Vermögensverwaltungs AG provides asset management services to private and institutional clients. The company was founded by Manfred Wergen and is headquartered in Wilen bei Wollerau, Switzerland. | Financial Conglomerates | Chairman | |
| Cordara SRL | Chief Executive Officer | ||
| Ecor Impianti SRL | Chief Executive Officer | ||
| City of Milan | Municipality | Corporate Officer/Principal | |
| REDHILL BIOPHARMA LTD. | Pharmaceuticals: Major | Director/Board Member | |
20 Minuten AG
 20 Minuten AG Publishing: NewspapersConsumer Services 20 Minuten AG publishes newspapers and provides online information services. It also provides French-language edition 20 minutes for the French-speaking agglomerations of Geneva and Lausanne. In France, the identically named 20 minutes editions are published by Schibsted and Ouest-France. The company is headquartered in Zurich, Switzerland. | Publishing: Newspapers | Founder | |
| PRIVATE EQUITY HOLDING AG | Investment Managers | Director/Board Member | |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Publishing: Newspapers | Founder | |
| University of St. Gallen | College/University | Doctorate Degree | |
| UBS | Investment Managers | Corporate Officer/Principal | |
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
| DKSH HOLDING AG | Medical Distributors | Director/Board Member | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
Banca Sella Holding SpA
 Banca Sella Holding SpA Major BanksFinance Banca Sella Holding SpA engages in the management, coordination and control, and development of strategic guidelines in its capacity as the Parent company of the Sella group. It also provides financial management solutions including proprietary trading and the management of centralized treasury activities, own securities portfolio and corporate finance activities. The company was founded by Gaudenzio Sella on August 23, 1886 and is headquartered in Biella, Italy. | Major Banks | Director/Board Member | |
| Namira Sgr SpA | Director/Board Member | ||
| Aedes Value Added SGR | Director/Board Member | ||
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
| Federation of Clinical Immunology Societies | President | ||
| University of Florence | College/University | Undergraduate Degree | |
| Dermogyn S.R.L. | Chief Tech/Sci/R&D Officer |
Statistik
International
| Italien | 23 |
| Schweiz | 14 |
| Deutschland | 5 |
| Vereinigte Staaten | 5 |
| Irland | 2 |
Sektoral
| Health Technology | 14 |
| Finance | 13 |
| Consumer Services | 8 |
| Commercial Services | 3 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 84 |
| Corporate Officer/Principal | 37 |
| Chairman | 30 |
| Chief Executive Officer | 14 |
| Independent Dir/Board Member | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Giuseppe Celasco
- Unternehmensverbindungen